53
Views
6
CrossRef citations to date
0
Altmetric
Original Article

Effect of a new marker, ADAM12, on Down risk figures in first trimester screening

, , , , &
Pages 602-607 | Received 12 Aug 2008, Accepted 14 Jan 2009, Published online: 21 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Yrtti Valinen, Jaana Marttala, Maarit Sahravand, Ilkka Jarvela, Timppa Honkasalo, Paivi Laitinen & Markku Ryynanen. (2012) Adding ADAM12 in risk calculation program does not improve the detection rate of trisomies 18 and 13 in first trimester screening. The Journal of Maternal-Fetal & Neonatal Medicine 25:6, pages 822-825.
Read now
Can Liao, Jin Han, Daljit Sahota, Dong-zhi LI, Qian Sun, Lin Lin, Jian-ying ZHOU, Xin Yang, Min Pan & Yi-ning Huang. (2010) Maternal serum ADAM12 in Chinese women undergoing screening for aneuploidy in the first trimester. The Journal of Maternal-Fetal & Neonatal Medicine 23:11, pages 1305-1309.
Read now

Articles from other publishers (4)

S Kate Alldred, Yemisi Takwoingi, Boliang Guo, Mary Pennant, Jonathan J Deeks, James P Neilson & Zarko Alfirevic. (2015) First trimester serum tests for Down's syndrome screening. Cochrane Database of Systematic Reviews 2015:11.
Crossref
I. Kerna, K. Kisand, P. Laitinen, A. E. Tamm, J. Kumm, M. Lintrop & A. O. Tamm. (2011) Association of ADAM12-S protein with radiographic features of knee osteoarthritis and bone and cartilage markers. Rheumatology International 32:2, pages 519-523.
Crossref
M. Sahraravand, I.Y. Järvelä, P. Laitinen, A.H. Tekay & M. Ryynänen. (2011) The secretion of PAPP-A, ADAM12, and PP13 correlates with the size of the placenta for the first month of pregnancy. Placenta 32:12, pages 999-1003.
Crossref
N. J. Cowans, A. Stamatopoulou, S. Jaakohuhta & K. Spencer. (2010) ADAM‐12 stability in first trimester maternal serum. Prenatal Diagnosis 30:6, pages 555-560.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.